Luminex Corp (NASDAQ:LMNX)

CAPS Rating: 2 out of 5

The COmpany develops, manufactures and sells proprietary biological testing technologies with applications throughout the life sciences industry.


Player Avatar bclan13 (99.07) Submitted: 2/6/2013 3:47:02 PM : Underperform Start Price: $18.02 LMNX Score: +7.27

Other technologies are coming in and taking away more and more of where Luminex's performance envelope has a competitive advantage (lab geeks' "mid plex"). I see particular pressures in genetic disease testing, e.g., CF on the diagnostics front. Longer term, there is a stable business for Luminex in HLA testing (particularly the protein tests) but this is not going to provide double digit growth forever - a requirement of a company with this kind of valuation.

Featured Broker Partners